Risk factors for severe RSV-induced lower respiratory tract infection over four consecutive epidemics.
about
Respiratory viruses other than influenza virus: impact and therapeutic advancesRisk factors for respiratory syncytial virus associated with acute lower respiratory infection in children under five years: Systematic review and meta-analysisRationale for full-season dosing for passive antibody prophylaxis of respiratory syncytial virusSocial, economic, and health impact of the respiratory syncytial virus: a systematic searchDefining the Epidemiology and Burden of Severe Respiratory Syncytial Virus Infection Among Infants and Children in Western CountriesDefining the Risk and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Preterm Infants Without Chronic Lung Disease or Congenital Heart DiseaseA predictive model for respiratory syncytial virus (RSV) hospitalisation of premature infants born at 33-35 weeks of gestational age, based on data from the Spanish FLIP Study.European risk factors' model to predict hospitalization of premature infants born 33-35 weeks' gestational age with respiratory syncytial virus: validation with Italian data.A novel six consecutive monthly doses of palivizumab prophylaxis protocol for the prevention of respiratory syncytial virus infection in high-risk preterm infants in Taiwan.Residential crowding and severe respiratory syncytial virus disease among infants and young children: a systematic literature review.The burden of respiratory syncytial virus infection in young childrenRespiratory syncytial virus and reactive airway diseaseMaternal alcohol ingestion reduces surfactant protein A expression by preterm fetal lung epitheliaExploring the origins of asthma: Lessons from twin studiesReduced PRF1 enhancer methylation in children with a history of severe RSV bronchiolitis in infancy: an association study.Review of the home care programmes for respiratory syncytial virus (RSV) prophylaxis in Ireland and The NetherlandsRespiratory Syncytial Virus-associated hospitalization in premature infants who did not receive palivizumab prophylaxis in Italy: a retrospective analysis from the Osservatorio StudyEpidemiological assessment of Respiratory Syncytial Virus infection in hospitalized infants, during the season 2005-2006 in Palermo, ItalyPalivizumab prophylaxis in 'late preterm' newborns.Respiratory syncytial virus-Host interaction in the pathogenesis of bronchiolitis and its impact on respiratory morbidity in later life.Severe Human Parechovirus Infections in Infants and the Role of Older Siblings.Epidemiology of respiratory virus infections among infants and young children admitted to hospital in Oman.Infants born before 32 weeks of gestation or with respiratory disease are most likely to receive palivizumab in the Netherlands.Epidemiology of respiratory syncytial virus-associated acute lower respiratory tract infection hospitalizations among HIV-infected and HIV-uninfected South African children, 2010-2011.Effects of parental and household smoking on the risk of respiratory syncytial virus (RSV) hospitalisation in late-preterm infants and the potential impact of RSV prophylaxis.Repeated ethanol exposure during late gestation alters the maturation and innate immune status of the ovine fetal lung.Low birth weight contributed to increased serum IL-6 levels in infantile respiratory syncytial virus infection.Discharge Criteria for Bronchiolitis: An Unmet Need.Respiratory syncytial virus risk factors in late preterm infants.Risk factors for severe bronchiolitis caused by respiratory virus infections among Mexican children in an emergency department.Respiratory viruses in neonates hospitalized with acute lower respiratory tract infections.Human respiratory syncytial virus and hospitalization in young children in Italy.
P2860
Q24655957-C596BC95-FA00-4417-84CF-231EEFCF1B03Q26774885-9513F4D8-F241-4C29-8FC3-6F5845233E78Q26825438-560FC793-1791-42B6-B419-B5856CFD7EB1Q26852865-800A4B93-F190-4ABB-B31B-993C61DBE538Q28069415-0DA00258-838A-4A8B-A6E9-1D351AF1FE45Q28072535-3252932B-CDA4-439C-8369-1EF3B3A1BFFEQ33390780-E52F7F06-96BB-4D71-A17B-2A6020332608Q33582499-19B5785D-D5B6-411A-8013-F6E836BFB5D8Q33817471-BF01D707-2FAC-49AA-8741-BDE9C72CDF6CQ34240719-54178BDA-A4AD-4B92-8D05-FF21D4F646D1Q34938343-BF39B755-2424-48B6-AFCC-0EEB452F97E4Q35065931-DA280F1F-489F-4418-BBC3-3ED072241833Q36155361-4DBF6631-100D-4B54-BDFF-F6802946CEBFQ36239426-33DED283-0145-4315-90F4-EDD613DEDF1CQ36295771-6CCF275C-8A15-4941-9BA8-151A94EF027EQ36582250-4603233C-7687-41ED-8F38-CB2E87809CB6Q36837007-E302586F-2ABD-420C-8525-097DAEDB39F6Q37205025-2947E6F9-D002-466B-992C-DAFF9B2440BEQ37778833-6CB018A1-18F4-40E8-9C2E-C0AB2D2C575BQ39198689-8D3648EE-18E6-4C7D-A2A9-F14680963CE4Q39927498-2E9A79B2-F8AE-4CCB-91A9-BB62973A8085Q40283024-AD9A9D91-7E82-4EFA-B729-A92CA6CB34C5Q40836385-C1C2C181-8D60-4AD4-882B-15BD5BCFE1EBQ42251265-EFEF5656-2B74-4144-9DF0-1B615FBBDCC7Q45352808-438B26D7-962A-4A4C-9BDD-A24A9A36B2C4Q46181256-6F9E9331-B769-46F2-B773-CE4A4FDEBC5FQ47147737-F6C46771-209D-4A93-A1F2-37F3E59BAACDQ47392075-337AE017-F01A-4066-B744-CAEC8AB682F7Q53183759-E965D3DE-67E1-4B42-8084-1443E22AE666Q54265000-40B476D5-2B6D-4448-8D14-C0FCA79C3557Q54292169-686029F9-0A8C-47FB-BD21-9701D0606D45Q55119368-91FA9AE6-CD6C-4FB8-948A-38DC9AA9A7BF
P2860
Risk factors for severe RSV-induced lower respiratory tract infection over four consecutive epidemics.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Risk factors for severe RSV-in ...... er four consecutive epidemics.
@ast
Risk factors for severe RSV-in ...... er four consecutive epidemics.
@en
type
label
Risk factors for severe RSV-in ...... er four consecutive epidemics.
@ast
Risk factors for severe RSV-in ...... er four consecutive epidemics.
@en
prefLabel
Risk factors for severe RSV-in ...... er four consecutive epidemics.
@ast
Risk factors for severe RSV-in ...... er four consecutive epidemics.
@en
P2093
P2860
P1476
Risk factors for severe RSV-in ...... er four consecutive epidemics.
@en
P2093
Angela Pistorio
Carlo Chezzi
Giovanni A Rossi
Marcello Lanari
Maria Cristina Arcangeletti
Maria Cristina Medici
Michela Silvestri
Osservatorio RSV Study Group
Rocco Merolla
Umberto Di Luzio Paparatti
P2860
P2888
P304
P356
10.1007/S00431-007-0418-Y
P577
2007-02-17T00:00:00Z